Wallace Capital Management Inc. Grows Stock Holdings in The Clorox Company (NYSE:CLX)

Wallace Capital Management Inc. increased its holdings in shares of The Clorox Company (NYSE:CLX) by 1.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,354 shares of the company’s stock after purchasing an additional 180 shares during the period. Wallace Capital Management Inc.’s holdings in Clorox were worth $1,822,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Core Wealth Advisors Inc. purchased a new position in shares of Clorox during the 4th quarter valued at approximately $29,000. Innealta Capital LLC acquired a new position in shares of Clorox during the 2nd quarter worth about $30,000. Trifecta Capital Advisors LLC raised its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the last quarter. GoalVest Advisory LLC purchased a new position in Clorox in the 1st quarter valued at about $31,000. Finally, First Foundation Advisors acquired a new stake in Clorox in the 1st quarter worth about $31,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.9 %

NYSE:CLX opened at $163.42 on Monday. The company has a market capitalization of $20.29 billion, a PE ratio of 84.67, a P/E/G ratio of 3.31 and a beta of 0.40. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The stock’s 50 day moving average price is $151.92 and its 200 day moving average price is $143.96. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. On average, research analysts anticipate that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. Clorox’s dividend payout ratio (DPR) is currently 252.85%.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.51% of the company’s stock.

Analysts Set New Price Targets

CLX has been the topic of several research reports. Argus upgraded Clorox to a “hold” rating in a research report on Tuesday, June 4th. Barclays upped their price objective on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a report on Monday, August 5th. BNP Paribas upgraded Clorox to a “strong sell” rating in a report on Friday, September 6th. TD Cowen assumed coverage on shares of Clorox in a research report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $143.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.